|

Propranolol hydrochloride Clinical Trials

4 actively recruiting trials across 2 locations

▲ +1 trial since June 2026

Also known as: 2-Propanol, 1-[(1-methylethyl)amino]-3-(1- naphthalenyloxy)-, hydrochloride, Inderal, Propranolol

Pipeline

Phase 1: 2Phase 2: 2

Top Sponsors

  • Weill Medical College of Cornell University1
  • Washington University School of Medicine1
  • Second Xiangya Hospital of Central South University1
  • Bai-Rong Xia1

Indications

Other2 trials

Chemotherapy Combined With Propranolol Hydrochloride as Neoadjuvant Therapy for Advanced High-grade Serous Ovarian Cancer
Phase 2
Propranolol Hydrochloride in Combination With Sintilimab and Platinum-based Chemotherapy for Treatment of Advanced Non-small Cell Lung Cancer
Phase 1

St Louis, Missouri1 trial

Propranolol for the Treatment of Kaposi Sarcoma in Adults

Washington University School of Medicine

Phase 2

New York, New York1 trial

Beta-blocker Administration for Cardiomyocyte Division

Weill Cornell Medicine

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.